Trials / Completed
CompletedNCT05266170
The Effect of EX1 Training in Normal Adults
The Effect of EX1 Training on Muscle Activity, Heart Rate, and Respiratory Metabolic Energy Consumption Rate in Normal Adults
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
In this study, when performing aerobic and anaerobic exercise with EX1 applied to normal adults between the ages of 19 and 65. The purpose of this study was to determine the effect on the muscle activity of the trunk and lower extremities compared with and without EX1.
Detailed description
In this study, aerobic exercise and anaerobic exercise for normal adults were divided into two visits for a total. For aerobic exercise, the investigators compared the aerobic treadmill walking program without EX1 \[30 minutes of moderate (64-76% HRmax, 12-14 of RPE) aerobic treadmill walking, 40 minutes including warm-up and cool-down times\], the aerobic treadmill walking program with EX1 \[30 minutes of moderate (64-76% HRmax, 12-14 of RPE) aerobic treadmill walking, 40 minutes including warm-up and cool-down times\] , and the high-intensity interval exercise (HIIT) program with EX1 \[High-intensity-low-intensity interval walking exercise was performed at treadmill speed (High: 90-95% HRmax, 15-17 of RPE/Low: 60-70% HRmax, 9-11 of RPE) and EX1 resistance strength (High: resistance intensity 7- 9/Low: Resistance strength 0-2)\] to check the effect on muscle activity, heart rate, and respiratory metabolic energy consumption rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | aerobic and anaerobic exercises | \[aerobic\] 1. Aerobic treadmill walking program without EX1 2. Aerobic treadmill walking program with EX1 3. High-intensity interval exercise (HIIT) program with EX1 \[anaerobic\] 1\. Fitness exercise program with EX1 |
Timeline
- Start date
- 2022-03-23
- Primary completion
- 2022-12-28
- Completion
- 2022-12-28
- First posted
- 2022-03-04
- Last updated
- 2023-03-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05266170. Inclusion in this directory is not an endorsement.